At Novartis, we are reimagining medicine
Novartis signs initial agreement to provide manufacturing capacity for CureVac COVID-19 vaccine candidate
The agreement will see Novartis utilizing its new high-tech production facilities in Kundl, Austria.
From Cancer to Cures
Our new monthly series "Let's Talk About the C Word: From Cancer to Cures" featuring President of Novartis Oncology Dr. Susanne Schaffert, addresses challenging cancer related topics.
Our commitment to ethical and responsible use of AI
AI is helping Novartis improve patients’ lives and optimize the healthcare ecosystem. We are committed to deploying AI systems in a transparent and responsible way.